Endoscopic and surgical treatment of necrotizing pancreatitis-a comparison of short- and long-term outcome.
Endoscopic necrosectomy
Necrotizing pancreatitis
Peri-interventional morbidity and mortality
Journal
Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285
Informations de publication
Date de publication:
12 Feb 2024
12 Feb 2024
Historique:
received:
15
11
2023
accepted:
29
01
2024
medline:
13
2
2024
pubmed:
13
2
2024
entrez:
12
2
2024
Statut:
epublish
Résumé
Acute necrotizing pancreatitis is still related to high morbidity and mortality rates. Minimal-invasive treatment options, such as endoscopic necrosectomy, may decrease peri-interventional morbidity and mortality. This study aims to compare the initial operative with endoscopic treatment on long-term parameters, such as endocrine and exocrine functionality, as well as mortality and recurrence rates. We included 114 patients, of whom 69 were treated with initial endoscopy and 45 by initial surgery. Both groups were further assessed for peri-interventional and long-term parameters. In the post-interventional phase, patients in the group of initial surgical treatment (IST) showed significantly higher rates of renal insufficiency (p < 0.001) and dependency on invasive ventilation (p < 0.001). The in-house mortality was higher in the surgical group, with 22% vs. 10.1% in the group of patients following initial endoscopic treatment (IET; p = 0.077). In long-term follow-up, the overall mortality was 45% for IST and 31.3% for IET (p = 0.156). The overall in-hospital stay and intensive care unit (ICU) stay were significantly shorter after IET (p < 0.001). In long-term follow-up, the prevalence of endocrine insufficiency was 50% after IST and 61.7% after IET (p = 0.281). 57.1% of the patients following IST and 16.4% of the patients following IET had persistent exocrine insufficiency at that point (p = < 0.001). 8.9% of the IET and 27.6% of the IST patients showed recurrence of acute pancreatitis (p = 0.023) in the long-term phase. In our cohort, an endoscopic step-up approach led to a reduced in-hospital stay and peri-interventional morbidity. The endocrine function appeared comparable in both groups, whereas the exocrine insufficiency seemed to recover in the endoscopic group in the long-term phase. These findings advocate for a preference for endoscopic treatment of acute necrotizing pancreatitis whenever feasible.
Sections du résumé
BACKGROUND
BACKGROUND
Acute necrotizing pancreatitis is still related to high morbidity and mortality rates. Minimal-invasive treatment options, such as endoscopic necrosectomy, may decrease peri-interventional morbidity and mortality. This study aims to compare the initial operative with endoscopic treatment on long-term parameters, such as endocrine and exocrine functionality, as well as mortality and recurrence rates.
METHODS
METHODS
We included 114 patients, of whom 69 were treated with initial endoscopy and 45 by initial surgery. Both groups were further assessed for peri-interventional and long-term parameters.
RESULTS
RESULTS
In the post-interventional phase, patients in the group of initial surgical treatment (IST) showed significantly higher rates of renal insufficiency (p < 0.001) and dependency on invasive ventilation (p < 0.001). The in-house mortality was higher in the surgical group, with 22% vs. 10.1% in the group of patients following initial endoscopic treatment (IET; p = 0.077). In long-term follow-up, the overall mortality was 45% for IST and 31.3% for IET (p = 0.156). The overall in-hospital stay and intensive care unit (ICU) stay were significantly shorter after IET (p < 0.001). In long-term follow-up, the prevalence of endocrine insufficiency was 50% after IST and 61.7% after IET (p = 0.281). 57.1% of the patients following IST and 16.4% of the patients following IET had persistent exocrine insufficiency at that point (p = < 0.001). 8.9% of the IET and 27.6% of the IST patients showed recurrence of acute pancreatitis (p = 0.023) in the long-term phase.
CONCLUSION
CONCLUSIONS
In our cohort, an endoscopic step-up approach led to a reduced in-hospital stay and peri-interventional morbidity. The endocrine function appeared comparable in both groups, whereas the exocrine insufficiency seemed to recover in the endoscopic group in the long-term phase. These findings advocate for a preference for endoscopic treatment of acute necrotizing pancreatitis whenever feasible.
Identifiants
pubmed: 38347181
doi: 10.1007/s00423-024-03244-9
pii: 10.1007/s00423-024-03244-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
58Informations de copyright
© 2024. The Author(s).
Références
Trikudanathan G, Wolbrink DRJ, van Santvoort HC, Mallery S, Freeman M, Besselink MG (2019) Current concepts in severe acute and necrotizing pancreatitis: an evidence-based approach. Gastroenterology 156(7):1994-2007 e3
doi: 10.1053/j.gastro.2019.01.269
pubmed: 30776347
Bakker OJ, van Santvoort H, Besselink MG, Boermeester MA, van Eijck C, Dejong K et al (2013) Extrapancreatic necrosis without pancreatic parenchymal necrosis: a separate entity in necrotising pancreatitis? Gut 62(10):1475–1480
doi: 10.1136/gutjnl-2012-302870
pubmed: 22773550
Yadav D, Lowenfels AB (2006) Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas 33(4):323–330
doi: 10.1097/01.mpa.0000236733.31617.52
pubmed: 17079934
Tan V, Charachon A, Lescot T, Chafai N, Le Baleur Y, Delchier JC et al (2014) Endoscopic transgastric versus surgical ne-crosectomy in infected pancreatic necrosis. Clin Res Hepatol Gastroenterol 38(6):770–776
doi: 10.1016/j.clinre.2014.06.016
pubmed: 25153999
Bausch D, Wellner U, Kahl S, Kuesters S, Richter-Schrag HJ, Utzolino S et al (2012) Minimally invasive operations for acute necrotizing pancreatitis: comparison of minimally invasive retroperitoneal necrosectomy with endoscopic transgastric necrosectomy. Surgery 152(3 Suppl 1):S128–S134
doi: 10.1016/j.surg.2012.05.021
pubmed: 22770962
Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J et al (2000) Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 355(9219):1955–1960
doi: 10.1016/S0140-6736(00)02327-8
pubmed: 10859041
van Brunschot S, Bakker OJ, Besselink MG, Bollen TL, Fockens P, Gooszen HG et al (2012) Treatment of necrotizing pancreatitis. Clin Gastroenterol Hepatol 10(11):1190–1201
doi: 10.1016/j.cgh.2012.05.005
pubmed: 22610008
Frossard JL, Steer ML, Pastor CM (2008) Acute pancreatitis. Lancet 371(9607):143–152
doi: 10.1016/S0140-6736(08)60107-5
pubmed: 18191686
van Brunschot S, van Grinsven J, van Santvoort HC, Bakker OJ, Besselink MG, Boermeester MA et al (2018) Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial. Lancet 391(10115):51–58
doi: 10.1016/S0140-6736(17)32404-2
pubmed: 29108721
Connor S, Raraty MG, Neoptolemos JP, Layer P, Runzi M, Steinberg WM et al (2006) Does infected pancreatic necrosis require immediate or emergency debridement? Pancreas 33(2):128–134
doi: 10.1097/01.mpa.0000234074.76501.a6
pubmed: 16868477
Buchler MW, Gloor B, Muller CA, Friess H, Seiler CA, Uhl W (2000) Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 232(5):619–626
doi: 10.1097/00000658-200011000-00001
pubmed: 11066131
pmcid: 1421214
de Madaria E, Martinez J, Lozano B, Sempere L, Benlloch S, Such J et al (2005) Detection and identification of bacterial DNA in serum from patients with acute pancreatitis. Gut 54(9):1293–1297
doi: 10.1136/gut.2004.047514
pubmed: 16099797
pmcid: 1774656
Baron TH, DiMaio CJ, Wang AY, Morgan KA (2020) American Gastroenterological Association Clinical Practice update: management of pancreatic necrosis. Gastroenterology 158(1):67-75 e1
doi: 10.1053/j.gastro.2019.07.064
pubmed: 31479658
Haghshenasskashani A, Laurence JM, Kwan V, Johnston E, Hollands MJ, Richardson AJ et al (2011) Endoscopic ne-crosectomy of pancreatic necrosis: a systematic review. Surg Endosc 25(12):3724–3730
doi: 10.1007/s00464-011-1795-x
pubmed: 21656324
van Brunschot S, Hollemans RA, Bakker OJ, Besselink MG, Baron TH, Beger HG et al (2018) Minimally invasive and endoscopic versus open necrosectomy for necrotising pancreatitis: a pooled analysis of individual data for 1980 pa-tients. Gut 67(4):697–706
pubmed: 28774886
Ausania F, Senra Del Rio P, Borin A, Guzman Suarez S, Rivera Irigoin R, Fort Martorell E et al (2020) Factors associated with mortality in patients with infected pancreatic necrosis: the “surgery effect.” Updates Surg 72(4):1097–1103
doi: 10.1007/s13304-020-00764-z
pubmed: 32306274
Bang JY, Arnoletti JP, Holt BA, Sutton B, Hasan MK, Navaneethan U et al (2019) An endoscopic transluminal approach, compared with minimally invasive surgery, reduces complications and costs for patients with necrotizing pancreatitis. Gastroenterology 156(4):1027–40 e3
doi: 10.1053/j.gastro.2018.11.031
pubmed: 30452918
Wronski M, Cebulski W, Witkowski B, Jankowski M, Klucinski A, Krasnodebski IW et al (2017) Comparison be-tween minimally invasive and open surgical treatment in necrotizing pancreatitis. J Surg Res 210:22–31
doi: 10.1016/j.jss.2016.10.022
pubmed: 28457332
Connor S, Alexakis N, Raraty MG, Ghaneh P, Evans J, Hughes M et al (2005) Early and late complications after pancreatic necrosectomy. Surgery 137(5):499–505
doi: 10.1016/j.surg.2005.01.003
pubmed: 15855920
Onnekink AM, Boxhoorn L, Timmerhuis HC, Bac ST, Besselink MG, Boermeester MA et al (2022) Endoscopic versus surgical step-up approach for infected necrotizing pancreatitis (ExTENSION): long-term follow-up of a randomized trial. Gastroenterology 163(3):712–22 e14
doi: 10.1053/j.gastro.2022.05.015
pubmed: 35580661
Bakker OJ, van Santvoort HC, van Brunschot S, Geskus RB, Besselink MG, Bollen TL et al (2012) Endoscopic transgastric vs surgical necrosectomy for infected necrotizing pancreatitis: a randomized trial. JAMA 307(10):1053–1061
doi: 10.1001/jama.2012.276
pubmed: 22416101